Supplemental Agreement Amendment No. 4 to Securities Purchase AgreementSecurities Purchase Agreement • January 10th, 2002 • Impax Laboratories Inc • Pharmaceutical preparations
JOINT FILING AGREEMENTJoint Filing Agreement • January 10th, 2002 • Impax Laboratories Inc • Pharmaceutical preparations
Pursuant to and in accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree to jointly file the Schedule 13D/A No. 3 dated December 27, 2001 and any amendments thereto with respect to the beneficial ownership by each of the undersigned of shares of common stock of Impax Laboratories, Inc. Such joint filings may be executed by one or more of us on behalf of each of the undersigned.
Supplemental Agreement Amendment No. 3 to Securities Purchase Agreement Supplemental Agreement dated and effective as of November 1, 2001, among China Development Industrial Bank Inc. (the "Seller"), the investors signatory hereto (individually, a...Securities Purchase Agreement • January 10th, 2002 • Impax Laboratories Inc • Pharmaceutical preparations
ARTICLE I DEFINITIONSSecurities Purchase Agreement • January 10th, 2002 • Impax Laboratories Inc • Pharmaceutical preparations • New York
Supplemental Agreement Amendment No. 1 to Securities Purchase AgreementSecurities Purchase Agreement • January 10th, 2002 • Impax Laboratories Inc • Pharmaceutical preparations
